What's new

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 6, Status: Authorised

May 27, 2025 - 12:15
 0
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Big Pharma-backed GlycoEra counting days to clinic with $130M raise for protein ...

Next Article

Website outages and upgrades

Related Posts

Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

Medicine shortage communication (MSC): Fiasp PumpCart a...

May 12, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Dermatology, PIP number: P/0120/2022

Opinion/decision on a Paediatric investigation plan (PI...

May 20, 2025  0